NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

Assessing PROCEPT BioRobotics (PRCT) Valuation As Fresh Analyst Downgrade Meets Confident Long-Term Growth Views

PROCEPT BioRobotics (PRCT) is back in focus after a flurry of analyst updates, including a downgrade from Bank of America that sits alongside more optimistic views on future utilization and long-term market potential. See our latest analysis for PROCEPT BioRobotics. The recent analyst flurry comes after a choppy stretch for PROCEPT BioRobotics, with a 7 day share price return of 6.73% following a 1 day decline of 4.79% and a 1 year total shareholder return of 62.20% in the red. This suggests...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Did Rising Volumes and Fintech Expansion Just Reframe Nasdaq’s (NDAQ) Earnings Story?

Nasdaq, Inc. recently reported its December 2025 trading volumes and Q4 operational metrics, while also setting January 29, 2026, for its fourth-quarter and full-year 2025 earnings release and investor conference call, which will feature senior management commentary and Q&A. These disclosures, alongside increased equity trading activity and expanding technology offerings such as Verafin and broader fintech solutions, have intensified attention on how Nasdaq’s business mix and transaction...
NYSE:UAA
NYSE:UAALuxury

Is Under Armour (UAA) Share Slide Creating A New Opportunity After Recent Price Rebound

If you are wondering whether Under Armour at around US$5.64 is a bargain or a value trap, you are not alone. The answer depends heavily on how you look at its valuation. The stock has recently shown sharp moves, with a 6.6% return over the last week and 28.8% over the last 30 days, against a 6.6% return year to date and longer term returns of a 31.3% decline over 1 year, a 50.9% decline over 3 years, and a 68.8% decline over 5 years. Recent headlines have focused on Under Armour's brand...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Assessing Iovance Biotherapeutics (IOVA) Valuation After Revenue Guidance And 1,000 Patient Milestone

Iovance Biotherapeutics (IOVA) recently told investors it expects to meet its 2025 revenue guidance of US$250 million to US$300 million, while surpassing 1,000 patients treated with its tumor infiltrating lymphocyte therapies globally. See our latest analysis for Iovance Biotherapeutics. The revenue guidance update and patient milestone come after a mixed stretch for investors, with the share price at US$2.45 and a 1-month share price return of 8.89% and a 90-day share price return of 16.67%,...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Is It Too Late To Consider Tesla (TSLA) After Its Strong Multi Year Share Price Run?

If you are wondering whether Tesla's share price still makes sense for you at today's levels, the key question is what you are really paying for when you buy the stock. Tesla last closed at US$445.01, with returns of 1.6% over the past week, a 0.4% decline over the past month, 1.6% year to date and 12.7% over the last year, while the 3 year and 5 year returns sit at 263.6% and 61.6% respectively. Recent headlines around Tesla have continued to focus on its role as a major electric vehicle...
NYSE:LW
NYSE:LWFood

How Investors Are Reacting To Lamb Weston (LW) Global Plant Consolidation And Capacity Cuts

Lamb Weston Holdings has already moved to close its Munro, Argentina plant and consolidate Latin American production at its newer Mar del Plata facility, while temporarily curtailing a production line in the Netherlands as part of its Focus to Win cost-efficiency program. This reshaping of its international manufacturing footprint highlights how the company is leaning on plant consolidation and capacity adjustments to pursue margin and efficiency gains across its global network. We’ll now...
NYSE:ABCB
NYSE:ABCBBanks

Ameris Bancorp (ABCB) Valuation Check After Recent Share Price Momentum And Analyst Comparisons

Ameris Bancorp (ABCB) is back on investors’ radar after recent trading, with the stock last closing at $79.13 and showing positive total returns over the past year, past 3 months, and month. See our latest analysis for Ameris Bancorp. The recent share price move to $79.13 comes on top of a 6.96% 7 day share price return and a 34.75% 1 year total shareholder return, which suggests momentum is building rather than fading. If Ameris Bancorp has caught your attention, it could be a good moment to...
NYSE:LNN
NYSE:LNNMachinery

Does Lindsay (LNN) Share Price Offer Value After Modest Recent Gains?

If you are wondering whether Lindsay's share price reflects its underlying worth, you are not alone. This article walks through what the current market price might be telling you about value. Lindsay recently closed at US$125.14, with returns of 3.3% over the past week, 2.6% over the last 30 days, 3.3% year to date, 2.8% over 1 year, and longer term returns of an 18.7% decline over 3 years and a 4.7% decline over 5 years. Recent company updates around operations, capital allocation or sector...
NYSE:FVRR
NYSE:FVRRProfessional Services

Fiverr International (FVRR) Is Down 7.8% After Pre‑Earnings Selloff Despite Forecast EPS Growth - Has The Bull Case Changed?

In recent days, Fiverr International’s shares fell even as the broader market advanced, ahead of an upcoming earnings report expected to show higher earnings per share and modest revenue growth. Analysts currently rate the stock as a Hold and highlight a forward price-to-earnings multiple below the industry average, raising questions about whether investors are discounting the company’s expected growth or factoring in elevated uncertainty. With the stock under pressure despite forecasts for...
NYSE:FLR
NYSE:FLRConstruction

Can Fluor’s (FLR) BASF Megaproject Milestone Redefine Its Standing In Global EPC Contracts?

Fluor Corporation recently achieved mechanical completion on BASF’s Zhanjiang Verbund project in China, delivering wide-ranging engineering, procurement, and construction scope with more than 75 million work hours recorded without a Lost Time Injury. This milestone reinforces Fluor’s capability to execute complex, integrated industrial sites at scale while maintaining rigorous safety performance across a workforce that peaked at about 13,000 people. We’ll now explore how this large, safely...
NYSE:SCI
NYSE:SCIConsumer Services

A Look At Service Corporation International (SCI) Valuation After Stagnant Volumes And Softer Cash Flow Metrics

Why Service Corporation International Is Back on Investors’ Radar Service Corporation International (SCI) is drawing attention after recent commentary flagged two years of flat funeral service volumes, softer free cash flow margins, and a declining return on invested capital. Taken together, these metrics are raising questions about the stock’s recent move. See our latest analysis for Service Corporation International. Against that backdrop, SCI’s share price has been relatively steady, with...
NasdaqGS:LKFN
NasdaqGS:LKFNBanks

Is Lakeland Financial (LKFN) Offering An Opportunity After Recent 10.6% One-Year Share Price Decline

If you are wondering whether Lakeland Financial is attractively priced or not, this article walks through what the current numbers might be telling you about the stock. The share price recently closed at US$57.13, with returns of 1.2% over the past week, a 3.7% decline over the past month, 1.2% year to date and a 10.6% decline over the last year, which can shape how investors think about both opportunity and risk. These moves sit against a backdrop of ongoing sector wide attention on...
NYSE:RITM
NYSE:RITMMortgage REITs

Is Rithm Capital (RITM) Pricing Reflecting Its Strong Run And Low P/E Ratio?

If you are looking at Rithm Capital and wondering whether the current share price offers value, this article will walk you through what the numbers are really saying about the stock. Rithm Capital's share price closed at US$11.57 recently, with returns of 5.4% over the past week, 3.2% over the past month, 5.4% year to date, 18.2% over one year, 74.2% over three years and 100.1% over five years. These figures naturally raise questions about how the current price compares with the company’s...
NYSE:TGLS
NYSE:TGLSBuilding

Will Softer Guidance and Sector Strains Change Tecnoglass' (TGLS) Resilience Narrative?

In recent days, Tecnoglass, a Colombia-based glass and window manufacturer listed on the NYSE, issued full-year EBITDA guidance that disappointed investors, while competitor Apogee Enterprises reported weaker-than-expected third-quarter results and reduced its fiscal 2026 outlook due to softer demand and higher costs. This combination of cautious outlooks has heightened concerns about sector-wide volume and cost pressures, prompting investors to reassess the resilience of Tecnoglass’s...
NYSE:ULS
NYSE:ULSProfessional Services

Is It Too Late To Consider UL Solutions (ULS) After A 72% One-Year Rally?

If you have been wondering whether UL Solutions is priced attractively right now, you are not alone. The stock has drawn attention from investors who are trying to work out what a fair value might look like. The share price last closed at US$84.38, with reported returns of 4.3% over the past week, 9.5% over the past month, and 72.5% over the past year. This naturally raises questions about what is already reflected in the price. Recent coverage has focused on UL Solutions as a newly listed...
NYSE:PAR
NYSE:PARSoftware

A Look At PAR Technology (PAR) Valuation After Fresh Insider Buying And Investor Conference Activity

PAR Technology (PAR) is back in focus after 10% shareholder Voss Capital deployed about US$7.1 million to buy 196,040 additional shares, alongside new CEO participation at the upcoming Needham Growth Conference. See our latest analysis for PAR Technology. Recent insider buying and the upcoming Needham Growth Conference appearance come after a mixed run. The share price has returned 4.6% year to date, but the 1 year total shareholder return is down 44.9%, suggesting sentiment is still in...
NYSE:LOB
NYSE:LOBBanks

Live Oak Bancshares (LOB) Is Up 5.5% After Disclosing Control Weakness And Restatements Plan - What's Changed

In December 2025, Live Oak Bancshares disclosed a material weakness in its internal controls over financial reporting, announced plans to restate prior-period financial statements due to cash flow misclassifications, and signaled that earlier filings should no longer be relied upon, while also scheduling its fourth quarter 2025 results release and conference call for January 21–22, 2026. The disclosure has already prompted a securities law investigation by Pomerantz LLP and coincided with...
NYSE:BEN
NYSE:BENCapital Markets

Is Franklin Resources (BEN) Pricing Reflect Recent 42% One Year Rally Accurately

If you are looking at Franklin Resources and wondering whether its current share price offers good value, the first step is to separate short term excitement from a clear view of what the business might be worth. The stock last closed at US$25.66, with returns of 7.8% over the past week, 10.1% over the past month, 7.8% year to date, 42.2% over the past year, 0.1% over three years and 23.0% over five years, which may have caught the attention of investors watching for changing risk and return...
NYSE:KSS
NYSE:KSSMultiline Retail

A Look At Kohl's (KSS) Valuation As Tariff Ruling Uncertainty Weighs On Retailers

The U.S. Supreme Court’s decision to delay a ruling on tariff legality has brought tariffs back into focus for import-heavy retailers, with Kohl's (KSS) seeing its shares fall about 5% on the news. See our latest analysis for Kohl's. Beyond today’s tariff driven setback, Kohl’s recent 30 day share price return of a 13.08% decline contrasts with a strong 46.92% 90 day share price gain and a 56.44% 1 year total shareholder return, suggesting momentum has cooled after a strong run. If tariffs...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Did Focus on AXPAXLI’s Pipeline Potential Just Shift Ocular Therapeutix's (OCUL) Investment Narrative?

In recent days, Ocular Therapeutix has drawn attention as analysts emphasized its expanding pipeline of hydrogel-based eye therapies, including AXPAXLI for wet age-related macular degeneration and PAXTRAVA for glaucoma, against a backdrop of declining revenue and a short cash runway. Investors now appear to be weighing the company’s significant projected revenue growth from next-generation retinal treatments against the heightened risk that future capital raises could dilute existing...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

Assessing J.B. Hunt Transport Services (JBHT) Valuation After Recent Wave Of Positive Analyst Actions

Recent analyst actions on J.B. Hunt Transport Services (JBHT) have drawn fresh attention to the stock, with several firms highlighting expectations for supportive truckload contract rates, stronger intermodal volumes, and improved rail service supporting operations. See our latest analysis for J.B. Hunt Transport Services. The latest share price of US$206.85 sits against a 90 day share price return of 50.89% and a 1 year total shareholder return of 20.06%. This suggests momentum has been...
NYSE:CRCL
NYSE:CRCLSoftware

Assessing Circle Internet Group (CRCL) Valuation After A Steep 90 Day Share Price Decline

Circle Internet Group (CRCL) has stayed in focus for investors after recent trading left the stock around $82.90, with mixed short term performance and a loss reported alongside annual revenue of about $2.41b. See our latest analysis for Circle Internet Group. While Circle Internet Group's latest 1 day share price return of 1.36% hints at a short term rebound, the 90 day share price return of a 37.64% decline suggests momentum has been fading relative to earlier in the year. If you are...
NYSE:BHE
NYSE:BHEElectronic

Benchmark Electronics (BHE) Valuation Check After Appointing New CTO Focused On AI And Automation

Benchmark Electronics (BHE) has drawn fresh attention after naming Josh Hollin as its new Chief Technology Officer, a leadership change that raises questions about how the company might apply AI, automation, and advanced manufacturing capabilities. See our latest analysis for Benchmark Electronics. The latest leadership news lands while Benchmark Electronics’ US$45.05 share price has a 90 day share price return of 25.24%, but only a 2.62% year to date share price return and a 0.99% 1 year...
NYSE:EQR
NYSE:EQRResidential REITs

Assessing Equity Residential (EQR) Valuation After Recent Slower Share Price Momentum

Equity Residential (EQR), a large U.S. apartment owner and S&P 500 member, continues to attract attention as investors weigh its recent share performance against fundamentals such as revenue, net income and overall value score. See our latest analysis for Equity Residential. Recent share price returns for Equity Residential have been slightly negative, with a 1-day share price return of a 3.87% decline and a year-to-date share price return of a 2.56% decline. Longer term total shareholder...